Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pendry

Showing results (201-210 of 229) with videos related to

Pageof 23
Sort By:
ACS Nano|June 21, 2013
Electron-energy loss study of nonlocal effects in connected plasmonic nanoprismsAeneas Wiener, Huigao Duan, Michel Bosman, et al.
British Journal of Clinical Pharmacology|March 11, 2014
Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumoursCathrine Leonowens, Carolyn Pendry, John Bauman, et al.
The European Respiratory Journal|June 15, 2007
Early discharge of patients with pulmonary embolism: a two-phase observational studyC W H Davies, J Wimperis, E S Green, et al.
Transfusion|October 8, 2015
Where do all the red blood cells (RBCs) go? Results of a survey of RBC use in England and North Wales in 2014Hazel Tinegate, Kate Pendry, Michael Murphy, et al.
Bone Marrow Transplantation|July 1, 1990
Autograft to eliminate minimal residual disease in AML in first remission--update on the Glasgow experienceA K Burnett, K Pendry, P M Rawlinson, et al.
Mbio|September 13, 2018
Mechanical Genomic Studies Reveal the Role of d-Alanine Metabolism in Pseudomonas aeruginosa Cell StiffnessRishi R Trivedi, John A Crooks, George K Auer, et al.
Proceedings. Biological Sciences|February 14, 2014
The evolution of traditional knowledge: environment shapes medicinal plant use in NepalC Haris Saslis-Lagoudakis, Julie A Hawkins, Simon J Greenhill, et al.
Nature Materials|February 26, 2008
A d.c. magnetic metamaterialF Magnus, B Wood, J Moore, et al.
Science (New York, N.Y.)|September 1, 2012
Probing the ultimate limits of plasmonic enhancementC Ciracì, R T Hill, J J Mock, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 27, 2013
Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancersMay Y K Ho, Michael J Morris, Jill L Pirhalla, et al.
Pageof 23

Showing results (201-210 of 229) with videos related to

Sort By:
Pageof 23
ACS Nano|June 21, 2013
Electron-energy loss study of nonlocal effects in connected plasmonic nanoprismsAeneas Wiener, Huigao Duan, Michel Bosman, et al.
British Journal of Clinical Pharmacology|March 11, 2014
Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumoursCathrine Leonowens, Carolyn Pendry, John Bauman, et al.
The European Respiratory Journal|June 15, 2007
Early discharge of patients with pulmonary embolism: a two-phase observational studyC W H Davies, J Wimperis, E S Green, et al.
Transfusion|October 8, 2015
Where do all the red blood cells (RBCs) go? Results of a survey of RBC use in England and North Wales in 2014Hazel Tinegate, Kate Pendry, Michael Murphy, et al.
Bone Marrow Transplantation|July 1, 1990
Autograft to eliminate minimal residual disease in AML in first remission--update on the Glasgow experienceA K Burnett, K Pendry, P M Rawlinson, et al.
Mbio|September 13, 2018
Mechanical Genomic Studies Reveal the Role of d-Alanine Metabolism in Pseudomonas aeruginosa Cell StiffnessRishi R Trivedi, John A Crooks, George K Auer, et al.
Proceedings. Biological Sciences|February 14, 2014
The evolution of traditional knowledge: environment shapes medicinal plant use in NepalC Haris Saslis-Lagoudakis, Julie A Hawkins, Simon J Greenhill, et al.
Nature Materials|February 26, 2008
A d.c. magnetic metamaterialF Magnus, B Wood, J Moore, et al.
Science (New York, N.Y.)|September 1, 2012
Probing the ultimate limits of plasmonic enhancementC Ciracì, R T Hill, J J Mock, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 27, 2013
Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancersMay Y K Ho, Michael J Morris, Jill L Pirhalla, et al.
Pageof 23